Roche
Search results
Novartis was created in March 1996 from the merger of Ciba-Geigy and Sandoz Laboratories, both Swiss companies. Ciba-Geigy. Ciba-Geigy was formed in 1970 by the merger of J. R. Geigy Ltd (founded in Basel in 1857) and CIBA (founded in Basel in 1859).
Sep 20, 2013 · The roots of Sandoz date back to 1886, when chemical company Kern & Sandoz was established in Basel by Dr Alfred Kern and Edouard Sandoz. By 1895, the company had produced its first pharmaceutical...
The history of Novartis traces the converging destinies of three companies: Geigy, a chemicals and dyes trading company founded in Basel, Switzerland in the middle of the 18th century; Ciba, which began producing dyes in 1859; and Sandoz, a chemical company founded in Basel in 1886.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Novartis AG was founded in 1996 with the merger of Ciba-Geigy Ltd. and Sandoz Ltd. Based in Basel, Switzerland, Novartis is an international leader in the development and marketing of pharmaceuticals and nutrition products, in addition to operating a number of research institutes dedicated to the study of gene therapy.
May 2, 2024 · Daniel Vasella (born August 15, 1953, Fribourg, Switzerland) is a Swiss doctor and businessman who served as chairman (1999–2013) and CEO (1996–2010) of the pharmaceutical company Novartis. Vasella received an M.D. degree in 1980 from the University of Bern, Switzerland.
Novartis Chief Executive (2017 – present) On September 5, 2017, Narasimhan was named CEO of Novartis, succeeding Joseph Jimenez. He publicly stated his desire to focus Novartis from a diversified company to a pure-play medicines company.
